Caricamento...
Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
BACKGROUND: Late-life depression is a common, chronic and recurring disorder for which guidelines recommend long-term therapy. The safety and efficacy of duloxetine for the treatment of major depressive disorder (MDD) were evaluated using data from elderly patients (age ≥ 65 years; n = 101) who part...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2004
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC544561/ https://ncbi.nlm.nih.gov/pubmed/15585058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2318-4-11 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|